Skylight Health Announces $12 Million Bought Deal Public Offering of Common Shares

NEXT STORY
Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
PREV STORY
Evaluation of Health and Economic Benefit of the PreTRM® Test-And-Treat Strategy to Improve Maternal and Infant Health Among Commercially Insured in the US
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment of Dr. Shelley Rankin to Company’s Scientific Advisory Board

author_avatar
NASDAQ Market News

World Market for Medical Gloves 2020-2024: Insights & Forecasts with Potential Impact of COVID-19

author_avatar
NASDAQ Market News

Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder

author_avatar
NASDAQ Market News